Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
复制标题
DOI:
10.1016/j.jaut.2008.11.001
复制
发表时间:
2009-02
影响因子:
12.8
通讯作者:
Gershwin ME
中科院分区:
文献类型:
--
作者:
Lan RY;Salunga TL;Tsuneyama K;Lian ZX;Yang GX;Hsu W;Moritoki Y;Ansari AA;Kemper C;Price J;Atkinson JP;Coppel RL;Gershwin ME
The emergence of new regulatory and pro-inflammatory immune cell subsets and cytokines dictates the need to re-examine the role of these subsets in various diseases involving the immune system. IL-17 has been recently identified as a key cytokine involved in numerous autoimmune processes. However, its role in liver autoimmune diseases remains unclear. Primary biliary cirrhosis (PBC) is characterized histologically by autoreactive CD4 and CD8 T cells surrounding damaged bile ducts. CD4+ T cells are a major source of IL-17, which compose a distinct T helper subset (Th17). Thus we set out determine the role of IL-17 in both human and a murine model of PBC in a liver-targeted manner. Our data demonstrate an increase in the frequency of IL-17+ lymphocytic infiltration in liver tissues from PBC patients and those with other liver dysfunctions as compared to healthy livers. IL-2 receptor α knockout mice, a recently identified murine model of human PBC, also demonstrate marked aggregations of IL-17 positive cells within portal tracts and increased frequencies of Th17 cells in the liver compared to the periphery. Interestingly, CD4+ T cells from livers of normal C57BL/6J mice also secreted higher levels of IL-17 relative to those from spleens, indicating a preferential induction of Th17 cells in liver tissues. Importantly, C57BL/6J cocultures of splenic CD4+ T cells and liver non-parenchymal cells increased IL-17 production approximately 10 fold compared to T cells alone, suggesting a role of the liver microenvironment in Th17 induction in cases of liver autoimmunity and other liver inflammatory diseases.
登录
查看更多内容
DOI:
10.1006/clin.1996.0129
发表时间:
1996-09-01
期刊:
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY
影响因子:
--
作者:
Krams, SM;Cao, S;Martinez, OM
通讯作者:
Martinez, OM
影响因子:
4.4
作者:
Rutitzky, Laura I.;Bazzone, Lindsey;Stadecker, Miguel J.
通讯作者:
Stadecker, Miguel J.
影响因子:
30.5
作者:
Denning, Timothy L.;Wang, Yi-Chong;Pulendran, Bali
通讯作者:
Pulendran, Bali
影响因子:
9.1
作者:
Nagano, T;Yamamoto, K;Tsuji, T
通讯作者:
Tsuji, T
DOI:
10.1196/annals.1309.031
发表时间:
2004-01-01
期刊:
ORAL TOLERANCE: NEW INSIGHTS AND PROSPECTS FOR CLINICAL APPLICATION
影响因子:
--
作者:
Battaglia, M;Gianfrani, C;Roncarolo, MG
通讯作者:
Roncarolo, MG